4Wolf G,Neilsion E G. Angiotension Ⅱ as a renal growth factor[J]. J Am Soc Nephrol, 1993,3(9) : 1531-1540.
5Timmermans P B M W M,Wong P C, Chin A T, et al.The preclinical basis of the therapeutic evaluation of losartan[J]. J Hypertens, 1995,13 (suppl) : s1.
6Keely F W, Elmoselhi A, Leenen F H. Enalapril suppresses normal accumulation of elastin and collagen in cardiovascular tissues of growing rats[J]. Am J Physiol, 1992,262(4 pt 2):H1013-1021.
7Wolf G, Ziyadeh FN. The role of angiotemin Ⅱ in diabetic nephropathy: Emphasis in rnonhernodyrmmie mechanisms.Am J Kidney Dis, 1997,29:153.
8Ahbate M,Zoja C, Rottoli D,et al. Antiproteinuric therapy while prevesating the abnormal protein traffic in proximal tubule abrogates protein - and complement-dependent interstitial inflammation in experimental renal disease.J Am Soc Nephrol,1999,10:804
9Mezzano S,Droguett M,Burgos E,et al.Overexpression of chmeokines,fibroenic cytokines,and myofibroblasts in human membranous nephropathy.Kidney Int,2000,57:147
10Sergio A,Mezzano,Marta Ruiz-Ortega,et al.Antiotensin Ⅱ and renal fibrosis.Hypertension,2001,38[Part 2]:635
